Growth hormon, insulin-like growth factor and insulin-like growth factor binding protein in young diabetic patients with the onset of diabetic angiopathy;Ocena stȩżenia hormonu wzrostu, insulinopobnego czynnika wzrostu i białka wia̧ża̧cego insulinopodobny czynnik wzrostu u młodzieży chorej na cukrzycȩ typu 1 i rozpoczynaja̧ca̧, siȩ angiopatiȩ cukrzycowa̧

Polski Merkuriusz Lekarski

Volumn 14, Issue 82, 2003, Pages 336-339

  Peczyńska, Jadwiga ^a   Urban, Mirosława ^a   Głowińska, Barbara ^a   Urban, Beata ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Klinika Okulistyki Dzieci cej   (Poland)

Author keywords

Diabetes mellitus type 1; Growth hormone; Insulin like growth factor 1; Protein binding IGF

Indexed keywords

GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; HUMAN GROWTH HORMONE; INSULIN; SIGNAL PEPTIDE; SOMATOMEDIN BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DISEASE COURSE; EVALUATION; FEMALE; GROWTH HORMONE RELEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC REGULATION; MICROVASCULAR ISCHEMIA; RADIOIMMUNOASSAY; SCHOOL CHILD; SYMPTOM; BLOOD; CHILD; METABOLISM; TIME;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; TIME FACTORS;

EID: 0038713100     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Akinci A. i wsp.: Insulin-like growth factor proteins (IGFBPs) in patients with insulin-dependent diabetes mellitus. Metabolism 2000, 49, 5, 626-633.
2. Barkai L. i wsp.: Association of hormonal changes of puberty with microalbuminuria in adolescents with type 1 diabetes. Diabetologia, 2000, 43, suppl. 1, A 256, 979. EASD Jerusalem 17-21 September.
3. Batch J.A. i wsp.: Changes in growth hormone concentrations during puberty in adolescents with insulin dependent diabetes mellitus. Clin Endocrinol., 1992, 36, 411-416.
4. Brismar K. i wsp.: IGF-I and IGFBP-I in Indian diabetic populations type 1, type 2 and malmutritional diabetes. Diabetologia, 2000, 43, suppl. 1, A 177, 680. EASD Jerusalem 17-21 September.
5. Carrel P.V. i wsp.: Growth hormone deficiency in adulthood and the effects of growth hormone replacement, a review. J. Clin. Endocrinol. Metab., 1998, 83, 6, 382-395.
6. Christ E.E. i wsp.: Low dose IGF-I therapy improves insulin sensitiviti but has no effect on VLDL APO B kinetics in type 1 diabetes. Diabetologia, 2000, 43, suppl. 1, A 176, 679. EASD Jerusalem 17-21 September.
7. Clemmons D.R. i wsp.: The combination of insulin-like growth factor I and insulin - like growth factor - biding protein -3 reduces insulin requirements in insulin-dependent type 1 diabetes, evidence for in vivo biological activity. J. Clin. Endocrinol. Metab., 2000, 85, 4 1518-1524.
8. Crowne E.C. i wsp.: The role of IGF-binding proteins in mediating the effekts of recombinat human IGF-I on insulin requirements in type 1 diabetes. J. Clin. Endocrinol. Metab., 2001, 86, 3686-3691.
9. Cummings E.A. i wsp.: Contribution of growth hormone and IGF-I to early diabetic nephropathy in ty. Diabetes, 1998, 47, 8, 1341-1346.
10. Feldmann B. i wsp.: Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins. Growth Horm. IGF Res., 2000, 10, 1, 53-59.
11. Garay-Sevilla M.E. i wsp.: Advanced glycosylation end products AGEs, insulin-like growth factor-1 IGF-1) and IGF-binding protein-3 IGFBP-3) in patients with type 2 diabetes mellitus. Diabetes Metab. Res. Rev., 2000, 16, 2, 106-113.
12. Heald A.H. i wsp.: Close relation of fasting cardiovascular risk in two populations. Diabetologia, 2001, 44, 333-339.
13. Hunt B.J. i wsp.: Endothelial cell activation - A central pathophysiological process. Br. Med. J., 1998, 316, 1328-1329.
14. Janssen J.A. i wsp.: Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy. Clin Endocrinol., 2000, 52, 1, 1-9.
15. Johansson J.O. i wsp.: Growth hormone-deficient adults are insulin resistant. Metab. Clin. Exp., 1995, 44, 16, 1126-1129.
16. Kajdaniuk D. i wsp.: Insulinopodobny czynnik wzrostowy-I aspekty patofizjologiczne i kliniczne. Pol. Merk. Lek., 1999, 41, 205-207.
17. Kinalska I. i wsp.: Kliniczne i metaboliczne efekty działania GH-IGF-1 u dorosłych, wpływ na gospodarkȩ wȩglowodanowa̧, lipidowȩ, białkowa̧ i układ krzepniȩcia. Endokrynol. Pol., 1999, 50, supl. 2, 40, 3, 71-73.
18. Korolkiewicz R.P. i wsp.: Exogenous insulin-like growth factor IGF) -1 improves the impaired healing of gastric mucosal lesions in diabetic rats. Pharmacol. Res., 2000, 412 221-229.
19. Krassowski J. i wsp.: Increased 24-hour growth hormone secretion in type 1 diabetes mellitus. Endokrynol. Pol., 1994, 45, 173-179.
20. Krassowski J. Zaburzenia wydzielania hormonu wzrostu w cukrzycy typu 1. Diabetol. Pol., 1998, 5, 62-21.
21. Matthew M. i wsp.: Regulatory actions of insulin-like growth factor-binding proteins. TEM 9, 5, 1998, 176-183.
22. Mooler N. i wsp.: Growth hormone, IGF-I and diabetic angiopathy revisited. Clin. Endocrinol., 2000, 52, 1, 11-12.
23. Niedżwiecka A.: Insulinopodpbny czynnik wzrostowy 1 (somatomedyna C) i jego białka wia̧ża̧ce 1 i 3 u dzieci, ze szczególnym uwzglȩdnieniem cukrzycy. Endokrynol., Diabetol. i Choroby Przem. Materii Wieku Rozwoj., 2000, 6, 11, 51-58. 24.
24. Romer T.E.: Rola hormonów w procesie wzrastania. Klin. Pediatr., 1997, 5, 190-194.
25. Rosmussen S.K. i wsp.: Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus. J. Clin. Endocrinol. Metab., 2000, 85, 4, 1606-1610.
26. Sen A. i wsp.: Albumin excretion rate, serum insulin-like growth factor-I and glomerrular filtra diabetes mellitus at puberty. J. Pediatr. Endocrinol. Metab., 1997, 10, 2, 209-215.
27. Shinada M. i wsp.: Proteolysis of of insulin-like factor-binding protein-3 is increased in urine from patients with diabetic nephropathy. J. Clin. Endocrinol. Matab., 2000, 85, 3, 1163-1169.
28. Spagnoli A. i wsp.: Evaluation of the components of insulin-like growth factor IGF) - IGF binding protein IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria, relationship with increase-durinary excretion of IGFBP-3 18 kD N-terminal fragment. Clin. Endocrinol., 1999, 51 5, 587-596.
29. Wollman H.A. i wsp.: Metabolic effects of growth hormone in children. Metabolism, 1995, 44, suppl. 4, 30.
30. Zachary T. i wsp.: Diabetic nephropathy. 36th Annual meeting of the Europen Association for the Study of Diabetes, September 17, 2000.